150 related articles for article (PubMed ID: 31791151)
21. Evaluation of iron oxide nanoparticle biocompatibility.
Hanini A; Schmitt A; Kacem K; Chau F; Ammar S; Gavard J
Int J Nanomedicine; 2011; 6():787-94. PubMed ID: 21589646
[TBL] [Abstract][Full Text] [Related]
22. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study.
Balivada S; Rachakatla RS; Wang H; Samarakoon TN; Dani RK; Pyle M; Kroh FO; Walker B; Leaym X; Koper OB; Tamura M; Chikan V; Bossmann SH; Troyer DL
BMC Cancer; 2010 Mar; 10():119. PubMed ID: 20350328
[TBL] [Abstract][Full Text] [Related]
23. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
Chen B; Wu W; Wang X
Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
[TBL] [Abstract][Full Text] [Related]
24. In vitro study on apoptotic cell death by effective magnetic hyperthermia with chitosan-coated MnFe₂O₄.
Oh Y; Lee N; Kang HW; Oh J
Nanotechnology; 2016 Mar; 27(11):115101. PubMed ID: 26871973
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of PEG-iron oxide core-shell composite nanoparticles for thermal therapy.
Wydra RJ; Kruse AM; Bae Y; Anderson KW; Hilt JZ
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4660-6. PubMed ID: 24094173
[TBL] [Abstract][Full Text] [Related]
26. A facile microwave synthetic route for ferrite nanoparticles with direct impact in magnetic particle hyperthermia.
Makridis A; Chatzitheodorou I; Topouridou K; Yavropoulou MP; Angelakeris M; Dendrinou-Samara C
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():663-70. PubMed ID: 27040263
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Intracellular Hyperthermia Efficiency by Magnetic Nanoparticles Modified with Nucleus and Mitochondria Targeting Peptides.
Wang X; Zhou J; Chen B; Tang Z; Zhang J; Li L; Tang J
J Nanosci Nanotechnol; 2016 Jun; 16(6):6560-6. PubMed ID: 27427753
[TBL] [Abstract][Full Text] [Related]
28. On the biocompatibility of Fe3O4 ferromagnetic nanoparticles with human blood cells.
Stamopoulos D; Manios E; Gogola V; Niarchos D; Pissas M
J Nanosci Nanotechnol; 2010 Sep; 10(9):6110-5. PubMed ID: 21133157
[TBL] [Abstract][Full Text] [Related]
29. RGD-Functionalized Fe
Arriortua OK; Insausti M; Lezama L; Gil de Muro I; Garaio E; de la Fuente JM; Fratila RM; Morales MP; Costa R; Eceiza M; Sagartzazu-Aizpurua M; Aizpurua JM
Colloids Surf B Biointerfaces; 2018 May; 165():315-324. PubMed ID: 29501962
[TBL] [Abstract][Full Text] [Related]
30. Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy.
Jurek PM; Zabłocki K; Waśko U; Mazurek MP; Otlewski J; Jeleń F
Int J Nanomedicine; 2017; 12():2941-2950. PubMed ID: 28442904
[TBL] [Abstract][Full Text] [Related]
31. An arsenal of magnetic nanoparticles; perspectives in the treatment of cancer.
Karponis D; Azzawi M; Seifalian A
Nanomedicine (Lond); 2016 Aug; 11(16):2215-32. PubMed ID: 27480599
[TBL] [Abstract][Full Text] [Related]
32. Magnetic mesoporous silica spheres for hyperthermia therapy.
Martín-Saavedra FM; Ruíz-Hernández E; Boré A; Arcos D; Vallet-Regí M; Vilaboa N
Acta Biomater; 2010 Dec; 6(12):4522-31. PubMed ID: 20601238
[TBL] [Abstract][Full Text] [Related]
33. The concept of ferrofluid preheating in the treatment of cancer by magnetic hyperthermia of tissues.
Malaescu I; Fannin PC; Marin CN; Lazic D
Med Hypotheses; 2018 Jan; 110():76-79. PubMed ID: 29317074
[TBL] [Abstract][Full Text] [Related]
34. Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancer.
Comes Franchini M; Baldi G; Bonacchi D; Gentili D; Giudetti G; Lascialfari A; Corti M; Marmorato P; Ponti J; Micotti E; Guerrini U; Sironi L; Gelosa P; Ravagli C; Ricci A
Small; 2010 Feb; 6(3):366-70. PubMed ID: 20020469
[No Abstract] [Full Text] [Related]
35. Auto-degradable and biocompatible superparamagnetic iron oxide nanoparticles/polypeptides colloidal polyion complexes with high density of magnetic material.
Wang B; Sandre O; Wang K; Shi H; Xiong K; Huang YB; Wu T; Yan M; Courtois J
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109920. PubMed ID: 31500039
[TBL] [Abstract][Full Text] [Related]
36. Specific Loss Power of Co/Li/Zn-Mixed Ferrite Powders for Magnetic Hyperthermia.
Barrera G; Coisson M; Celegato F; Martino L; Tiwari P; Verma R; Kane SN; Mazaleyrat F; Tiberto P
Sensors (Basel); 2020 Apr; 20(7):. PubMed ID: 32290270
[TBL] [Abstract][Full Text] [Related]
37. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
38. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
39. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
[TBL] [Abstract][Full Text] [Related]
40. Biocompatibility of Fe₃O₄@Au composite magnetic nanoparticles in vitro and in vivo.
Li Y; Liu J; Zhong Y; Zhang J; Wang Z; Wang L; An Y; Lin M; Gao Z; Zhang D
Int J Nanomedicine; 2011; 6():2805-19. PubMed ID: 22131827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
